58-17-102.   Exceptions. No coverage is required under §§ 58-17-100 to 58-17-106, inclusive, for the following:

             (1)      Any drug that has not been fully licensed or approved by the FDA;

             (2)      The use of any drug if the FDA has determined that use to be contraindicated; or

             (3)      Any experimental drug not otherwise approved for any indication by the FDA.

Source: SL 2000, ch 242, § 3.

---